BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu R, Brawner AT, Li S, Liu JJ, Kim H, Xue H, Pang ZP, Kim WY, Hart RP, Liu Y, Jiang P. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome. Cell Stem Cell 2019;24:908-926.e8. [PMID: 31130512 DOI: 10.1016/j.stem.2019.04.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 53] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Ma C, Seong H, Li X, Yu X, Xu S, Li Y, Chimenti I. Human Brain Organoid: A Versatile Tool for Modeling Neurodegeneration Diseases and for Drug Screening. Stem Cells International 2022;2022:1-20. [DOI: 10.1155/2022/2150680] [Reference Citation Analysis]
2 Sharma V, Nehra S, Singhal N. Generation of AAVS1-EGFP Reporter cell lines from an Isogenic pair of Trisomy 21 and Euploid human iPSCs. Stem Cell Research 2022. [DOI: 10.1016/j.scr.2022.102890] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Krzisch MA, Wu H, Yuan B, Whitfield TW, Liu XS, Fu D, Garrett-engele CM, Khalil AS, Lungjangwa T, Shih J, Chang AN, Warren S, Cacace A, Andrykovich KR, Rietjens RG, Wallace O, Sur M, Jain B, Jaenisch R. Fragile X syndrome patient-derived neurons developing in the mouse brain show FMR1 -dependent phenotypes. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.08.020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Klein JA, Haydar TF. Neurodevelopment in Down syndrome: Concordance in humans and models. Front Cell Neurosci 2022;16:941855. [DOI: 10.3389/fncel.2022.941855] [Reference Citation Analysis]
5 Jin M, Xu R, Wang L, Alam MM, Ma Z, Zhu S, Martini AC, Jadali A, Bernabucci M, Xie P, Kwan KY, Pang ZP, Head E, Liu Y, Hart RP, Jiang P. Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer's disease. Cell Stem Cell 2022;29:1135-1153.e8. [PMID: 35803230 DOI: 10.1016/j.stem.2022.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zheng H, Feng Y, Tang J, Ma S. Interfacing brain organoids with precision medicine and machine learning. Cell Reports Physical Science 2022;3:100974. [DOI: 10.1016/j.xcrp.2022.100974] [Reference Citation Analysis]
7 Risgaard KA, Sorci IA, Mohan S, Bhattacharyya A. Meta-Analysis of Down Syndrome Cortical Development Reveals Underdeveloped State of the Science. Front Cell Neurosci 2022;16:915272. [DOI: 10.3389/fncel.2022.915272] [Reference Citation Analysis]
8 Giffin-Rao Y, Sheng J, Strand B, Xu K, Huang L, Medo M, Risgaard KA, Dantinne S, Mohan S, Keshan A, Daley RA Jr, Levesque B, Amundson L, Reese R, Sousa AMM, Tao Y, Wang D, Zhang SC, Bhattacharyya A. Altered patterning of trisomy 21 interneuron progenitors. Stem Cell Reports 2022:S2213-6711(22)00209-0. [PMID: 35623352 DOI: 10.1016/j.stemcr.2022.05.001] [Reference Citation Analysis]
9 Stagni F, Bartesaghi R. The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives. Front Cell Neurosci 2022;16:903729. [DOI: 10.3389/fncel.2022.903729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Barnhart AJ, Dierickx K. The Many Moral Matters of Organoid Models: A systematic review of reasons. Med Health Care Philos 2022. [PMID: 35532849 DOI: 10.1007/s11019-022-10082-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhao Y, Wu J, Li D, Liu J, Chen W, Hou Z, Liu K, Jiang L, Chen X, Wang L, Hu B, Zong F, Wang Y, Wang Y. Human ESC-derived immunity- and matrix- regulatory cells ameliorated white matter damage and vascular cognitive impairment in rats subjected to chronic cerebral hypoperfusion. Cell Prolif 2022;:e13223. [PMID: 35437845 DOI: 10.1111/cpr.13223] [Reference Citation Analysis]
12 Borghi R, Magliocca V, Trivisano M, Specchio N, Tartaglia M, Bertini E, Compagnucci C. Modeling PCDH19-CE: From 2D Stem Cell Model to 3D Brain Organoids. Int J Mol Sci 2022;23:3506. [PMID: 35408865 DOI: 10.3390/ijms23073506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wu CI, Vinton EA, Pearse RV 2nd, Heo K, Aylward AJ, Hsieh YC, Bi Y, Adeleye S, Fancher S, Duong DM, Seyfried NT, Schwarz TL, Young-Pearse TL. APP and DYRK1A regulate axonal and synaptic vesicle protein networks and mediate Alzheimer's pathology in trisomy 21 neurons. Mol Psychiatry 2022. [PMID: 35194165 DOI: 10.1038/s41380-022-01454-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Borges AC, Broersen K, Leandro P, Fernandes TG. Engineering Organoids for in vitro Modeling of Phenylketonuria. Front Mol Neurosci 2022;14:787242. [DOI: 10.3389/fnmol.2021.787242] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
15 Lu X, Yang J, Xiang Y. Modeling human neurodevelopmental diseases with brain organoids. Cell Regen 2022;11:1. [PMID: 34982276 DOI: 10.1186/s13619-021-00103-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Klein JA, Li Z, Rampam S, Cardini J, Ayoub A, Shaw P, Rachubinski AL, Espinosa JM, Zeldich E, Haydar TF. Sonic Hedgehog Pathway Modulation Normalizes Expression of Olig2 in Rostrally Patterned NPCs With Trisomy 21. Front Cell Neurosci 2022;15:794675. [DOI: 10.3389/fncel.2021.794675] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Robles DA, Boreland AJ, Pang ZP, Zahn JD. A Cerebral Organoid Connectivity Apparatus to Model Neuronal Tract Circuitry. Micromachines (Basel) 2021;12:1574. [PMID: 34945423 DOI: 10.3390/mi12121574] [Reference Citation Analysis]
18 Bhattacharya A, Choi WWY, Muffat J, Li Y. Modeling Developmental Brain Diseases Using Human Pluripotent Stem Cells-Derived Brain Organoids - Progress and Perspective. J Mol Biol 2021;:167386. [PMID: 34883115 DOI: 10.1016/j.jmb.2021.167386] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Foliaki ST, Schwarz B, Groveman BR, Walters RO, Ferreira NC, Orrù CD, Smith A, Wood A, Schmit OM, Freitag P, Yuan J, Zou W, Bosio CM, Carroll JA, Haigh CL. Neuronal excitatory-to-inhibitory balance is altered in cerebral organoid models of genetic neurological diseases. Mol Brain 2021;14:156. [PMID: 34635127 DOI: 10.1186/s13041-021-00864-w] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
20 Ishihara K. Genes Associated with Disturbed Cerebral Neurogenesis in the Embryonic Brain of Mouse Models of Down Syndrome. Genes (Basel) 2021;12:1598. [PMID: 34680993 DOI: 10.3390/genes12101598] [Reference Citation Analysis]
21 Cirnaru MD, Song S, Tshilenge KT, Corwin C, Mleczko J, Galicia Aguirre C, Benlhabib H, Bendl J, Apontes P, Fullard J, Creus-Muncunill J, Reyahi A, Nik AM, Carlsson P, Roussos P, Mooney SD, Ellerby LM, Ehrlich ME. Unbiased identification of novel transcription factors in striatal compartmentation and striosome maturation. Elife 2021;10:e65979. [PMID: 34609283 DOI: 10.7554/eLife.65979] [Reference Citation Analysis]
22 Liu X, Bibineyshvili Y, Robles DA, Boreland AJ, Margolis DJ, Shreiber DI, Zahn JD. Fabrication of a Multilayer Implantable Cortical Microelectrode Probe to Improve Recording Potential. J Microelectromech Syst 2021;30:569-81. [PMID: 34539168 DOI: 10.1109/jmems.2021.3092230] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Kleiman RJ, Engle SJ. Human inducible pluripotent stem cells: Realization of initial promise in drug discovery. Cell Stem Cell 2021;28:1507-15. [PMID: 34478628 DOI: 10.1016/j.stem.2021.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Jalink P, Caiazzo M. Brain Organoids: Filling the Need for a Human Model of Neurological Disorder. Biology (Basel) 2021;10:740. [PMID: 34439972 DOI: 10.3390/biology10080740] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Xu R, Boreland AJ, Li X, Erickson C, Jin M, Atkins C, Pang ZP, Daniels BP, Jiang P. Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology. Stem Cell Reports 2021;16:1923-37. [PMID: 34297942 DOI: 10.1016/j.stemcr.2021.06.011] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
26 Park Y, Page N, Salamon I, Li D, Rasin MR. Making sense of mRNA landscapes: Translation control in neurodevelopment. Wiley Interdiscip Rev RNA 2021;:e1674. [PMID: 34137510 DOI: 10.1002/wrna.1674] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Tang XY, Xu L, Wang J, Hong Y, Wang Y, Zhu Q, Wang D, Zhang XY, Liu CY, Fang KH, Han X, Wang S, Wang X, Xu M, Bhattacharyya A, Guo X, Lin M, Liu Y. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome. J Clin Invest 2021;131:135763. [PMID: 33945512 DOI: 10.1172/JCI135763] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
28 Sharma A, Sances S, Workman MJ, Svendsen CN. Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery. Cell Stem Cell 2020;26:309-29. [PMID: 32142662 DOI: 10.1016/j.stem.2020.02.011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 80] [Article Influence: 46.0] [Reference Citation Analysis]
29 Szu J, Wojcinski A, Jiang P, Kesari S. Impact of the Olig Family on Neurodevelopmental Disorders. Front Neurosci 2021;15:659601. [PMID: 33859549 DOI: 10.3389/fnins.2021.659601] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Duchon A, Del Mar Muniz Moreno M, Martin Lorenzo S, Silva de Souza MP, Chevalier C, Nalesso V, Meziane H, Loureiro de Sousa P, Noblet V, Armspach JP, Brault V, Herault Y. Multi-influential genetic interactions alter behaviour and cognition through six main biological cascades in Down syndrome mouse models. Hum Mol Genet 2021;30:771-88. [PMID: 33693642 DOI: 10.1093/hmg/ddab012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
31 Costamagna G, Comi GP, Corti S. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids. Int J Mol Sci 2021;22:2659. [PMID: 33800815 DOI: 10.3390/ijms22052659] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
32 Willner MJ, Xiao Y, Kim HS, Chen X, Xu B, Leong KW. Modeling SARS-CoV-2 infection in individuals with opioid use disorder with brain organoids. J Tissue Eng 2021;12:2041731420985299. [PMID: 33738089 DOI: 10.1177/2041731420985299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Guo Z, Cui Y, Shi X, Birchler JA, Albizua I, Sherman SL, Qin ZS, Ji T. An empirical bayesian approach for testing gene expression fold change and its application in detecting global dosage effects. NAR Genom Bioinform 2020;2:lqaa072. [PMID: 33575620 DOI: 10.1093/nargab/lqaa072] [Reference Citation Analysis]
34 Quach TT, Stratton HJ, Khanna R, Kolattukudy PE, Honnorat J, Meyer K, Duchemin AM. Intellectual disability: dendritic anomalies and emerging genetic perspectives. Acta Neuropathol 2021;141:139-58. [PMID: 33226471 DOI: 10.1007/s00401-020-02244-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
35 Rosner M, Reithofer M, Fink D, Hengstschläger M. Human Embryo Models and Drug Discovery. Int J Mol Sci 2021;22:E637. [PMID: 33440617 DOI: 10.3390/ijms22020637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Cheffer A, Flitsch LJ, Krutenko T, Röderer P, Sokhranyaeva L, Iefremova V, Hajo M, Peitz M, Schwarz MK, Brüstle O. Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction. Mol Autism 2020;11:99. [PMID: 33308283 DOI: 10.1186/s13229-020-00383-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Li Y, Tang P, Cai S, Peng J, Hua G. Organoid based personalized medicine: from bench to bedside. Cell Regen 2020;9:21. [PMID: 33135109 DOI: 10.1186/s13619-020-00059-z] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
38 Lovett ML, Nieland TJF, Dingle YL, Kaplan DL. Innovations in 3-Dimensional Tissue Models of Human Brain Physiology and Diseases. Adv Funct Mater 2020;30:1909146. [PMID: 34211358 DOI: 10.1002/adfm.201909146] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
39 Shou Y, Liang F, Xu S, Li X. The Application of Brain Organoids: From Neuronal Development to Neurological Diseases. Front Cell Dev Biol 2020;8:579659. [PMID: 33195219 DOI: 10.3389/fcell.2020.579659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
40 Moyer AJ, Gardiner K, Reeves RH. All Creatures Great and Small: New Approaches for Understanding Down Syndrome Genetics. Trends Genet 2021;37:444-59. [PMID: 33097276 DOI: 10.1016/j.tig.2020.09.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
41 Chen XQ, Salehi A, Pearn ML, Overk C, Nguyen PD, Kleschevnikov AM, Maccecchini M, Mobley WC. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model. Alzheimers Dement 2021;17:271-92. [PMID: 32975365 DOI: 10.1002/alz.12185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
42 Sukhinich KK, Aleksandrova MA. Cerebral Organoids: A Model of Brain Development. Russ J Dev Biol 2020;51:231-45. [DOI: 10.1134/s1062360420040074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Nam KH, Yi SA, Jang HJ, Han JW, Lee J. In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid. Arch Pharm Res 2020;43:877-89. [PMID: 32761309 DOI: 10.1007/s12272-020-01260-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Rondal JA. Down syndrome: A curative prospect? AIMS Neurosci 2020;7:168-93. [PMID: 32607419 DOI: 10.3934/Neuroscience.2020012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
45 Zhang DY, Song H, Ming GL. Modeling neurological disorders using brain organoids. Semin Cell Dev Biol 2021;111:4-14. [PMID: 32561297 DOI: 10.1016/j.semcdb.2020.05.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Chen A, Guo Z, Fang L, Bian S. Application of Fused Organoid Models to Study Human Brain Development and Neural Disorders. Front Cell Neurosci 2020;14:133. [PMID: 32670022 DOI: 10.3389/fncel.2020.00133] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
47 Lin VJT, Hu J, Zolekar A, Yan LJ, Wang YC. Urine Sample-Derived Cerebral Organoids Suitable for Studying Neurodevelopment and Pharmacological Responses. Front Cell Dev Biol 2020;8:304. [PMID: 32528947 DOI: 10.3389/fcell.2020.00304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
48 Xu R, Li X, Boreland AJ, Posyton A, Kwan K, Hart RP, Jiang P. Human iPSC-derived mature microglia retain their identity and functionally integrate in the chimeric mouse brain. Nat Commun 2020;11:1577. [PMID: 32221280 DOI: 10.1038/s41467-020-15411-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 47] [Article Influence: 15.0] [Reference Citation Analysis]
49 Manley WF, Anderson SA. Dosage Counts: Correcting Trisomy-21-Related Phenotypes in Human Organoids and Xenografts. Cell Stem Cell 2019;24:835-6. [PMID: 31173710 DOI: 10.1016/j.stem.2019.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Reiche L, Küry P, Göttle P. Aberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis? Cells 2019;8:E1591. [PMID: 31817891 DOI: 10.3390/cells8121591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
51 Chhibber T, Bagchi S, Lahooti B, Verma A, Al-Ahmad A, Paul MK, Pendyala G, Jayant RD. CNS organoids: an innovative tool for neurological disease modeling and drug neurotoxicity screening. Drug Discov Today 2020;25:456-65. [PMID: 31783130 DOI: 10.1016/j.drudis.2019.11.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
52 Costamagna G, Andreoli L, Corti S, Faravelli I. iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery. Cells 2019;8:E1438. [PMID: 31739555 DOI: 10.3390/cells8111438] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
53 Shou JW, Cheung CK, Gao J, Shi WW, Shaw PC. Berberine Protects C17.2 Neural Stem Cells From Oxidative Damage Followed by Inducing Neuronal Differentiation. Front Cell Neurosci 2019;13:395. [PMID: 31551713 DOI: 10.3389/fncel.2019.00395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]